Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer

NCT01827943 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Bladder Cancer

Interventions

DRUG: Temsirolimus

Sponsor

Institut Bergonié

Collaborators

[object Object]